The US health industry is looking less like a special case, an asterisk in the US economy, and is beginning to behave like other industries. So for PwC Health Research Institute's Top health industry issues of 2019 report, instead of focusing on issues only US health organizations face, HRI for the first time is featuring business issues common to all industries: deals, business and tax strategy, risk and regulatory issues, workforce trends and digital transformation. The details may be healthcare, but the business issues are shared with many other parts of the economy.

Featured Speakers

Gurpreet Singh

US Health Services Sector Leader

Gurpreet is a Partner and the US Health Services Sector (Payer/Provider) Leader at PwC. He is responsible for delivering strategies that enhance growth, improve financial performance and leverage emerging technologies to gain competitive advantage. He has expertise in Patient Outcomes, Real World Evidence and Health Information Technology/Digital Strategies that drive innovation for the largest healthcare organizations.

Karen Young

US Pharmaceutical and Life Sciences Leader

Karen is a Partner and the US Pharmaceutical and Life Sciences Leader at PwC. She is responsible for setting the strategy for the firm’s practice across Audit, Tax and Advisory. She leads over 3,000 professionals in delivering against that strategy with the highest level of client service and thought leadership working within our global network to achieve results. Karen has served many pharmaceutical and life sciences clients. She specializes in the areas of acquisitions, divestitures, strategic alliances, pharmaceutical gross-to-net issues and tax structuring.

Rob Friz

US Health Services Tax Leader

Rob is a Partner in PwC’s National Tax Services practice, and serves as the Firm's U.S. Tax Health Services Sector leader. His practice focuses on providing advice regarding tax and business issues associated with healthcare, higher education, pension trust, and other exempt organizations, as well as their related corporate and joint venture entities. Rob's clients include a number of the largest healthcare systems, health plans, universities, and pension trusts in the U.S.

Kathy Michael

US Pharmaceutical and Life Sciences Tax Leader

Kathy is a Tax Partner with PwC and has over 30 years of tax experience specializing in serving multinational companies. Kathy is the US Pharmaceutical and Life Sciences Tax Leader and is PwC’s Florham Park, NJ Tax Practice Leader. She has served major multinationals and various other pharmaceutical, medical device, and healthcare clients. She advises clients on federal, state, local, and international income tax matters.

Benjamin Isgur

PwC’s Health Research Institute Leader

Ben leads PwC's Health Research Institute. In this role, he oversees thought leadership and research initiatives for the firm and clients. He also consults with healthcare systems, trade associations, and policy groups on strategic planning, and industry intelligence and trends. Ben is a published writer and his research is often cited by health leaders across the industry.


Register now for this webinar